Back to Search
ERIC FELDMAN, M.D.
M.D.
Specialist
NPI: 1477504355Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
PMID 18349031·Ann Oncol·2008
8-other
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.
PMID 18548095·Leukemia·2008
3-trial
Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells.
PMID 16378159·Ann Surg Oncol·2006
7-preclinical
Farnesyltransferase inhibitors in myelodysplastic syndrome.
PMID 15865870·Curr Hematol Rep·2005
6-review
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
PMID 15961759·J Clin Oncol·2005
3-trial
Pretreatment clinical and laboratory findings in dogs with primary hyperparathyroidism: 210 cases (1987-2004).
PMID 16178397·J Am Vet Med Assoc·2005
7-preclinical
Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.
PMID 15036196·J Gastrointest Surg·2004
8-other
Pseudo-Meigs' syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literature.
PMID 15047245·Gynecol Oncol·2004
5-case
Regional treatment options for patients with ocular melanoma metastatic to the liver.
PMID 14993024·Ann Surg Oncol·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2760 ATLANTIC AVE
LONG BEACH, CA 90806 - Phone
- (562) 424-6666
Quick Facts
- NPI
- 1477504355
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile